Omnicell (FRA:OC9) Cyclically Adjusted FCF per Share: €1.81 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OC9 Omnicell Inc FRA:OC9
76 GF Score
Price €39.80
GF Value €33.66
! 7 Warning Signs
View Full Analysis

What is Omnicell Cyclically Adjusted FCF per Share?

Omnicell FRA:OC9 -1.00% 76 Cyclically Adjusted FCF per Share is €1.81 as of Mar. 2026. GuruFocus rates FRA:OC9 with a GF Score™ of 76/100 and a GF Value™ of €33.66. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Omnicell's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.727. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.81 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Omnicell's average Cyclically Adjusted FCF Growth Rate was 9.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Omnicell was 24.60% per year. The lowest was -0.50% per year. And the median was 15.70% per year.

As of today (2026-07-19), Omnicell's current stock price is €39.80. Omnicell's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €1.81. Omnicell's Cyclically Adjusted Price-to-FCF of today is 21.99.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Omnicell was 129.04. The lowest was 13.11. And the median was 66.74.


Omnicell  (FRA:OC9) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Omnicell's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=39.80/1.81
=21.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Omnicell was 129.04. The lowest was 13.11. And the median was 66.74.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Omnicell Cyclically Adjusted FCF per Share Related Terms


Omnicell Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Omnicell's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell Cyclically Adjusted FCF per Share Chart

Omnicell Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.37 1.62 1.80 1.76

Omnicell Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 1.74 1.79 1.76 1.81

FRA:OC9 vs TDOC, SDGR, OMDA: Cyclically Adjusted FCF per Share Comparison

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted Price-to-FCF falls into.


FRA:OC9
76GF Score
Omnicell Inc FRA:OC9
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omnicell Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Omnicell's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.727/330.2130*330.2130
=0.727

Current CPI (Mar. 2026) = 330.2130.

Omnicell Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.260 241.018 -0.356
201609 0.026 241.428 0.036
201612 0.421 241.432 0.576
201703 0.542 243.801 0.734
201706 0.097 244.955 0.131
201709 -0.528 246.819 -0.706
201712 -0.132 246.524 -0.177
201803 0.088 249.554 0.116
201806 0.178 251.989 0.233
201809 0.050 252.439 0.065
201812 0.731 251.233 0.961
201903 0.205 254.202 0.266
201906 0.248 256.143 0.320
201909 0.878 256.759 1.129
201912 0.413 256.974 0.531
202003 0.238 258.115 0.304
202006 0.584 257.797 0.748
202009 0.519 260.280 0.658
202012 1.209 260.474 1.533
202103 0.802 264.877 1.000
202106 1.029 271.696 1.251
202109 0.482 274.310 0.580
202112 0.764 278.802 0.905
202203 -0.594 287.504 -0.682
202206 -0.447 296.311 -0.498
202209 0.117 296.808 0.130
202212 1.372 296.797 1.526
202303 -0.018 301.836 -0.020
202306 1.179 305.109 1.276
202309 0.880 307.789 0.944
202312 0.525 306.746 0.565
202403 0.757 312.332 0.800
202406 0.911 314.175 0.958
202409 0.183 315.301 0.192
202412 0.865 315.605 0.905
202503 0.202 319.799 0.209
202506 0.495 322.561 0.507
202509 0.260 324.800 0.264
202512 0.345 324.054 0.352
202603 0.727 330.213 0.727

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €1.81 mean?
Omnicell (FRA:OC9) has a Cyclically Adjusted FCF per Share of €1.81 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Omnicell and its competitors.
Is Omnicell's Cyclically Adjusted FCF per Share too high?
Omnicell's current Cyclically Adjusted FCF per Share is €1.81. Overall, Omnicell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Omnicell's Cyclically Adjusted FCF per Share compare to TDOC and SDGR?
Omnicell's Cyclically Adjusted FCF per Share of €1.81 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Omnicell and its competitors. Omnicell's current Cyclically Adjusted FCF per Share is €1.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Omnicell (FRA:OC9) has a current Cyclically Adjusted FCF per Share of €1.81. The stock's GF Value™ is €33.66, compared to a current price of €39.80 — trading 18.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €1.81. Omnicell's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Omnicell (FRA:OC9), the current Cyclically Adjusted FCF per Share is €1.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omnicell (FRA:OC9) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be overvalued. The current stock price of €39.80 is trading 18.2% above its estimated GF Value™ of €33.66.

Key valuation signals for FRA:OC9:

  • Cyclically Adjusted FCF per Share: €1.81
  • GF Value™: €33.66 vs. price of €39.80 (18.2% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the FRA:OC9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omnicell Business Description

Other Exchanges OMCL:USAOMCL:Mexico
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
76GF Score

Get the complete analysis for FRA:OC9

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€39.80
Price
€33.66
GF Value